Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1991-05-14 to 1991-05-28
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Study carried out under GLP and EU method B3

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1992
Report date:
1992

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
EU Method B.3 (Acute Toxicity (Dermal))
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Test type:
fixed dose procedure

Test material

Constituent 1
Chemical structure
Reference substance name:
3,20-bis(ethylenedioxy)pregna-5,7-diene
EC Number:
243-175-0
EC Name:
3,20-bis(ethylenedioxy)pregna-5,7-diene
Cas Number:
19592-55-3
Molecular formula:
C25H36O4
IUPAC Name:
(1S,3aR,9aR,9bS,11aS)-9a,11a-dimethyl-1-(2-methyl-1,3-dioxolan-2-yl)-1,2,3,3a,6,8,9,9a,9b,10,11,11a-dodecahydrospiro[cyclopenta[a]phenanthrene-7,2'-[1,3]dioxolane]
Test material form:
solid: crystalline
Details on test material:
- Name of test material (as cited in study report): Proketal
- Physical state: Solid powder
-

Test animals

Species:
rat
Strain:
Wistar
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Harlan/CPB, Zeist, The Netherlands
- Weight at study initiation: Males: 175g to 200g, females: 150g-175g
- Housing: The rats were housed continuously in Macrolon cages containing sawdust, with two or three animals per cage, except for the application period of 24 hours; then the rats were housed singly.
- Diet (e.g. ad libitum): RHM-TM, Hope Farms, Woerden, The Netherlands
- Water (e.g. ad libitum): Ad libitum
- Acclimation period: 6 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21-23
- Humidity (%): 40-60%
- Air changes (per hr): 16
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Type of coverage:
occlusive
Vehicle:
other: Tragacant mucilage 1.25% in distilled water
Details on dermal exposure:
TEST SITE
- Area of exposure: back and flanks


REMOVAL OF TEST SUBSTANCE
- Washing (if done): Wiped
- Time after start of exposure: 24 hours

TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 2000mg/kg
- Concentration (if solution): 6.4ml/kg
- Constant volume or concentration used: yes
Duration of exposure:
24 hours
Doses:
1
No. of animals per sex per dose:
5 male and 5 female
Control animals:
not specified
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: 0, 0.5, 1.5, 3 and 24 hours
- Necropsy of survivors performed: no

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
None
Clinical signs:
During the application period, when the rats were wearing collars, chromodacryorrhoea and dirty noses were noticed in males and females. The production of red tears is a normal physiological phenomenon, but is not always noticed due to grooming. In the present study normal grooming behaviour was hindered during the application period by the collars fitted around the neck of the rats. Therefore, chromodacryrrhoea and dirty noses are not considered to be treatment-related signs. No other clinical signs were observed.
Body weight:
 Male and female rats gained normal weights one day prior to dosing. Upon exposure to a single dermal dose of 2000 mg/kg of proketal females but not males lost some weight during the first few days after treatment. Thereafter, normal growth was observed in males, but weight-gains of females were relatively low during the second week of the study (see table below).
 
Other findings:
During the application period, chromodacryorrhea and dirty noses were noticed from 0-0. 5 hours after the start of the treatment up to 24 hours after administration in both males and females. Upon removal of the collars and patches, these signs disappeared. No further symptoms were observed.

Any other information on results incl. tables

Sex

Dose

Animalnumber

1daybeforedosing

Dayofdosing

2  daysafterdosing

7daysafterdosing

14daysafterdosing

 

(mg/kg)

 

 

 

M

2000

1

200

204

204

223

251

 

 

2

211

220

220

244

265

 

 

3

197

204

210

222

241

 

 

4

197

198

209

230

255

 

 

5

190

195

198

219

251

 

 

 

Mean

 

199.0

 

204.2

 

208.2

 

227.6

 

252.6

F

2000

1

166

171 

160

168

164

 

 

2

145

150

145

150

154

 

 

3

153

160

153

159

165

 

 

4

162

167

170

175

184

 

 

5

157

159

158

167

168

Applicant's summary and conclusion

Interpretation of results:
not classified
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
Acute dermal LD50 is greater than 2000 mg/kg in both male and female rats.
Executive summary:

.